Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 May 24 | NBIX Neurocrine Biosciences | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,869 | 0.00 | 2,869 |
22 May 24 | ALGN Align Technology | RSU Common Stock | Grant | Acquire A | No | No | 0.0001 | 1,148 | 0.11 | 1,148 |
17 May 24 | NBIX Neurocrine Biosciences | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,199 | 0.00 | 4,199 |
17 May 24 | NBIX Neurocrine Biosciences | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,199 | 0.00 | 0 |
17 May 24 | ALGN Align Technology | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,029 | 0.00 | 2,143 |
17 May 24 | ALGN Align Technology | RSU Common Stock | Option exercise | Dispose M | No | No | 0.0001 | 1,029 | 0.10 | 0 |
14 Mar 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | Yes | 139.4139 | 20,000 | 2.79 mm | 0 |
14 Mar 24 | NBIX Neurocrine Biosciences | Common Stock | Option exercise | Acquire M | No | No | 39.79 | 20,000 | 795.80 k | 20,000 |
14 Mar 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | Yes | 139.4216 | 20,000 | 2.79 mm | 0 |
14 Mar 24 | NBIX Neurocrine Biosciences | Common Stock | Option exercise | Acquire M | No | No | 39.79 | 20,000 | 795.80 k | 20,000 |